Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2983

1.

Ambiguous genitalia: An overview of 7 years experience at the Children's Hospital & Institute of Child Health, Lahore, Pakistan.

Manzoor J, Aftab S, Yaqoob M.

Pak J Med Sci. 2019 Jan-Feb;35(1):151-155. doi: 10.12669/pjms.35.1.289.

2.

Cryptozoospermia after treatment with clomiphene citrate following long-term use of intramuscular testosterone undecanoate depot injection (Nebido®).

Grubić Kezele T.

Horm Mol Biol Clin Investig. 2019 Mar 14. pii: /j/hmbci.ahead-of-print/hmbci-2018-0078/hmbci-2018-0078.xml. doi: 10.1515/hmbci-2018-0078. [Epub ahead of print]

PMID:
30870141
3.

Peyronie's disease and testosterone deficiency: Is there a link?

Aditya I, Grober ED, Krakowsky Y.

World J Urol. 2019 Mar 11. doi: 10.1007/s00345-019-02723-9. [Epub ahead of print]

PMID:
30859271
4.

Late-onset Hypogonadism and Testosterone Therapy - A Summary of Guidelines from the American Urological Association and the European Association of Urology.

Fode M, Salonia A, Minhas S, Burnett AL, Shindel AW.

Eur Urol Focus. 2019 Mar 8. pii: S2405-4569(19)30056-2. doi: 10.1016/j.euf.2019.02.021. [Epub ahead of print]

PMID:
30858073
5.

Kallmann Syndrome.

Sonne J, Lopez-Ojeda W.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Feb 20.

6.

The effects of testosterone replacement therapy on the prostate: a clinical perspective.

Miah S, Tharakan T, Gallagher KA, Shah TT, Winkler M, Jayasena CN, Ahmed HU, Minhas S.

F1000Res. 2019 Feb 25;8. pii: F1000 Faculty Rev-217. doi: 10.12688/f1000research.16497.1. eCollection 2019. Review.

7.

Exercise dependence, eating disorder symptoms and biomarkers of Relative Energy Deficiency in Sports (RED-S) among male endurance athletes.

Torstveit MK, Fahrenholtz IL, Lichtenstein MB, Stenqvist TB, Melin AK.

BMJ Open Sport Exerc Med. 2019 Jan 10;5(1):e000439. doi: 10.1136/bmjsem-2018-000439. eCollection 2019.

8.

Clinical, biochemical, and molecular overview of transaldolase deficiency and evaluation of the endocrine function: Update of 34 patients.

Williams M, Valayannopoulos V, Altassan R, Chung WK, Heijboer AC, Keng WT, Lapatto R, McClean P, Mulder MF, Tylki-Szymańska A, Walenkamp ME, Alfadhel M, Alakeel H, Salomons GS, Eyaid W, Wamelink MMC.

J Inherit Metab Dis. 2019 Jan;42(1):147-158. doi: 10.1002/jimd.12036.

PMID:
30740741
9.

Remission of type 2 diabetes and pleiotropic effects of long-term testosterone treatment for "late-onset" hypogonadism: A case report.

Haider A, Haider K, Saad F, Hanefeld M.

SAGE Open Med Case Rep. 2019 Jan 16;7:2050313X18823454. doi: 10.1177/2050313X18823454. eCollection 2019.

10.

Benefits and risks of testosterone therapy in older men.

Cardona Attard C, Fava S.

Minerva Urol Nefrol. 2019 Jan 28. doi: 10.23736/S0393-2249.19.03301-0. [Epub ahead of print]

PMID:
30700083
11.

Predictive Factors of Efficacy Maintenance after Testosterone Treatment Cessation.

Park MG, Yeo JK, Park SG, Na W, Moon DG.

J Clin Med. 2019 Jan 29;8(2). pii: E151. doi: 10.3390/jcm8020151.

12.

Ex Vivo Evaluation of Intravaginal Progesterone and Testosterone to Treat the Luteal-phase Deficiency and Vaginal Atrophy.

Laque LC, Raposo NR, Brandão MAF, Ferreira AO, Polonini HC.

Int J Pharm Compd. 2019 Jan-Feb;23(1):77-81.

PMID:
30668539
13.

A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.

Javed Z, Papageorgiou M, Deshmukh H, Kilpatrick ES, Mann V, Corless L, Abouda G, Rigby AS, Atkin SL, Sathyapalan T.

Nutrients. 2019 Jan 17;11(1). pii: E188. doi: 10.3390/nu11010188.

14.

Correlation between serum P450arom and sex hormones in males with late-onset hypogonadism: a pilot study.

Wang JQ, Wang DW, Wang XL, Wang DC, Lin XM, Sun LB.

Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):70-74. doi: 10.26355/eurrev_201901_16749.

15.
16.

Testosterone Replacement Therapy and Rehospitalization in Older Men with Testosterone Deficiency in a Post-Acute Care Setting.

Al-Lami RA, Graham JE, Deer RR, Westra J, Williams SB, Kuo YF, Baillargeon J.

Am J Phys Med Rehabil. 2019 Jan 8. doi: 10.1097/PHM.0000000000001127. [Epub ahead of print]

PMID:
30624240
17.

Testosterone, testosterone therapy and prostate cancer.

Yassin A, AlRumaihi K, Alzubaidi R, Alkadhi S, Al Ansari A.

Aging Male. 2019 Jan 7:1-9. doi: 10.1080/13685538.2018.1524456. [Epub ahead of print]

PMID:
30614347
18.

FSH β-subunit mutations in two sisters: the first report from the Indian sub-continent and review of previous cases.

Misgar RA, Wani AI, Bankura B, Bashir MI, Roy A, Das M.

Gynecol Endocrinol. 2019 Jan 2:1-4. doi: 10.1080/09513590.2018.1529159. [Epub ahead of print]

PMID:
30602350
19.

Anti-Müllerian Hormone as a Diagnostic Marker in Egyptian Infertile Polycystic Ovary Syndrome Females: Correlations with Vitamin D, Total Testosterone, Dyslipidemia and Anthropometric Parameters.

Bakeer E, Radwan R, El Mandoury A, El Rahman AA, Gad M, El Maksoud SA.

J Med Biochem. 2018 Dec 1;37(4):448-455. doi: 10.1515/jomb-2017-0068. eCollection 2018 Dec.

Supplemental Content

Loading ...
Support Center